Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FASLG overexpression
i
Other names:
FASLG, APT1LG1, CD178, FasL, TNFSF6, Fas ligand
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
356
Related biomarkers:
Expression
Others
‹
›
Associations
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
FASLG overexpression
Non Small Cell Lung Cancer
FASLG overexpression
Non Small Cell Lung Cancer
pembrolizumab
Sensitive: C3 – Early Trials
AACR 2023 - 1 week (New C3)
pembrolizumab
Sensitive
:
C3
AACR 2023 - 1wk
pembrolizumab
Sensitive: C3 – Early Trials
AACR 2023 - 1 week
pembrolizumab
Sensitive
:
C3
AACR 2023 - 1 week - (New C3)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login